[HTML][HTML] First-line venetoclax combinations in chronic lymphocytic leukemia
…, V Lindström, C da Cunha-Bang… - … England Journal of …, 2023 - Mass Medical Soc
Background Randomized trials of venetoclax plus anti-CD20 antibodies as first-line treatment
in fit patients (ie, those with a low burden of coexisting conditions) with advanced chronic …
in fit patients (ie, those with a low burden of coexisting conditions) with advanced chronic …
Patients with CLL have a lower risk of death from COVID-19 in the Omicron era
CU Niemann, C da Cunha-Bang… - Blood, The Journal …, 2022 - ashpublications.org
Previous studies have shown that patients with chronic lymphocytic leukemia (CLL) and
coronavirus disease 2019 (COVID-19) have high mortality rates. Infection with the Omicron …
coronavirus disease 2019 (COVID-19) have high mortality rates. Infection with the Omicron …
[HTML][HTML] A randomized phase III study of venetoclax-based time-limited combination treatments (RVe, GVe, GIVe) vs standard chemoimmunotherapy (CIT: FCR/BR) in …
Background: For fit CLL patients (pts), continuous BTK inhibitor treatment is replacing CIT
as standard of care in frontline setting, particularly in pts with unfavorable prognostic factors. …
as standard of care in frontline setting, particularly in pts with unfavorable prognostic factors. …
The CLL-IPI applied in a population-based cohort
C da Cunha-Bang, I Christiansen… - Blood, The Journal of …, 2016 - ashpublications.org
The rapid development in treatment options for patients with chronic lymphocytic leukemia (CLL)
in parallel with a much more detailed understanding of the underlying pathogenesis …
in parallel with a much more detailed understanding of the underlying pathogenesis …
[HTML][HTML] And predictors of infection among patients prior to treatment of chronic lymphocytic leukemia: a Danish nationwide cohort study
…, C Brieghel, JL Biccler, C da Cunha-Bang… - …, 2018 - ncbi.nlm.nih.gov
With the international prognostic index for patients with chronic lymphocytic leukemia (CLL-IPI),
we have a tool to identify patients with a high risk of progression. 1, 2 Despite improved …
we have a tool to identify patients with a high risk of progression. 1, 2 Despite improved …
High karyotypic complexity is an independent prognostic factor in patients with CLL treated with venetoclax combinations
Complex karyotypes have been associated with inferior outcomes in chronic lymphocytic
leukemia (CLL) treated with chemoimmunotherapy (CIT), whereas their prognostic impact in …
leukemia (CLL) treated with chemoimmunotherapy (CIT), whereas their prognostic impact in …
Mapping comorbidity in chronic lymphocytic leukemia: impact of individual comorbidities on treatment, mortality, and causes of death
…, CU Niemann, K Rostgaard, C da Cunha-Bang… - Leukemia, 2021 - nature.com
Comorbid conditions are highly prevalent in chronic lymphocytic leukemia (CLL), nevertheless,
detailed information on the association of specific comorbidities with CLL prognosis is …
detailed information on the association of specific comorbidities with CLL prognosis is …
Targeting Bruton's tyrosine kinase across B-cell malignancies
C da Cunha-Bang, CU Niemann - Drugs, 2018 - Springer
… Caspar da Cunha-Bang … Caspar da Cunha-Bang … Caspar da Cunha-Bang declares
no conflicts of interest that might be relevant to the contents of this article. …
no conflicts of interest that might be relevant to the contents of this article. …
The value of EBV DNA in early detection of post-transplant lymphoproliferative disorders among solid organ and hematopoietic stem cell transplant recipients
…, A Mocroft, H Sengeløv, C Da Cunha-Bang… - Journal of Cancer …, 2018 - Springer
Purpose Emerging EBV DNAemia in plasma is considered an early sign of post-transplant
lymphoproliferative disorder (PTLD). The aim of this study was to quantify the extent of benefit …
lymphoproliferative disorder (PTLD). The aim of this study was to quantify the extent of benefit …
[HTML][HTML] Early stimulated immune responses predict clinical disease severity in hospitalized COVID-19 patients
…, T Faitova, MA Andersen, C da Cunha-Bang… - Communications …, 2022 - nature.com
Background The immune pathogenesis underlying the diverse clinical course of COVID-19
is poorly understood. Currently, there is an unmet need in daily clinical practice for early …
is poorly understood. Currently, there is an unmet need in daily clinical practice for early …